Clinical Trials Logo

Filter by:
NCT ID: NCT02380339 Recruiting - Hypoglycemia Clinical Trials

A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Uncontrolled diabetes is associated with increased risk for micro-vascular complication. Hypoglycemia is one of the major barriers in achieving good glucose control. Hypoglycemia is associated with a range of unpleasant symptoms including palpitations, tremor, hunger, sweating, confusion, difficulties in thinking as well as other idiosyncratic symptoms. Fear of hypoglycemia (FOH) refers to phobic avoidance reactions associated with hypoglycemia FOH may increase behavioral attempts to avoid hypoglycemia including decreased consumption of insulin and/or increased consumption of carbohydrates, resulting in poor glycemic control and an increased risk of diabetic complication. In this study, the investigators present a novel system, which simultaneously employs BioFeedback and Virtual Reality in order to cope with fear of hypoglycemia.

NCT ID: NCT02380040 Recruiting - Clinical trials for Patent Ductus Arteriosus

Plethismographic Perfusion Index in Neonates

Start date: March 2015
Phase: N/A
Study type: Observational

Photoplethismography will be measured and compared in newborns suffering from patent ductus arteriosus and normal controls.

NCT ID: NCT02379884 Completed - Respiratory Arrest Clinical Trials

Mechanical Ventilation in Internal Medicine Elderly Patients - Choosing Wisely

VentWise
Start date: March 2015
Phase:
Study type: Observational

This is a prospective observational study evaluating all patients requiring mechanical ventilation. Data will be gathered regarding the events prior to ventilation and the indication for mechanical ventilation. In-hospital and post-admission outcome will be monitored.

NCT ID: NCT02378688 Completed - Crohn's Disease Clinical Trials

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Start date: March 2015
Phase: Phase 2
Study type: Interventional

The primary objectives of the study are: - To evaluate the safety and tolerability of MT-1303 in subjects with moderate to severe active Crohn's Disease(CD) - To evaluate the clinical efficacy of MT-1303 in subjects with moderate to severe active CD.

NCT ID: NCT02378662 Terminated - Clinical trials for Anemia of End Stage Renal Disease

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Start date: April 2015
Phase: Phase 2
Study type: Interventional

The objectives of this study are to assess safety and to evaluate the biologic activity of TARGTEPO treatment in Peritoneal Dialysis patients

NCT ID: NCT02378649 Completed - Clinical trials for Pulmonary Hypertension

PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension

Start date: March 2015
Phase: Phase 4
Study type: Interventional

A randomized, placebo controlled, single center clinical trial for evaluation of efficacy and safety of Sildenafil administration in the cardiac ICU following Mitral Valve (MV) Surgery in patients with pre-operative Significant Pulmonary Hypertension.

NCT ID: NCT02378480 Completed - Clinical trials for Bacterial Infections

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Start date: June 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to linezolid in the treatment of adults with acute bacterial skin and skin structure infections.

NCT ID: NCT02377921 Completed - GNE Myopathy Clinical Trials

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

GNEM
Start date: May 20, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of 6 g/day aceneuramic acid extended-release (Ace-ER) treatment of participants with GNEM on upper extremity muscle strength (upper extremity composite [UEC] score) as measured by dynamometry.

NCT ID: NCT02377869 Recruiting - CLL Clinical Trials

Heavy Light Chain in Chronic Lymphocytic Leukemia

Start date: January 2015
Phase: N/A
Study type: Observational

Recently, a novel assay for detecting heavy/light chain (HLC) ratios has been reported which enables improvement in paraprotein detection and monitoring in multiple myeloma and other plasma-cell dyscrasias. The prognostic and biological role of the HLC assay has as yet not been studied in CLL. Aims of the proposed study: 1. To quantify and analyze the prognostic significance of HLC ratios in the serum of CLL patients. (In addition to FLC) 2. To study the different patterns of Immunoglobulin's subclass antibodies in the serum of patients with CLL and compare them to those of to healthy volunteers. 3. To perform a sub-analysis in patients with CLL who have autoimmune phenomenon (AIHA and ITP)

NCT ID: NCT02376556 Completed - Dry Eye Syndrome Clinical Trials

The Effect of Eyelid Surgery on Dry Eye - a Prospective Study

Start date: March 2015
Phase:
Study type: Observational

The investigators aim to assess the effect of blepharoplasty with or without muller muscle resection on the symptoms of dry eye syndrome. this will be an observational study in which patients undergoing the aforementioned surgeries will be followed up and monitored for dry eye symptoms.